Study Of Thrombotic Thrombocytopenic Purpura Medicine Demonstrates Safety
Source: Pixabay

Study Of Thrombotic Thrombocytopenic Purpura Medicine Demonstrates Safety

Caplacizumab is a medicine that has been developed to treat acquired thrombotic thrombocytopenic purpura (TTP). TTP causes serious symptoms. such as thrombocytopenia, a condition in which a patient doesn't have enough platelets. A…

Continue Reading Study Of Thrombotic Thrombocytopenic Purpura Medicine Demonstrates Safety
Study of LJPC-401 Treatment for Hereditary Hemochromatosis Launches into Phase II
Source: Pixabay

Study of LJPC-401 Treatment for Hereditary Hemochromatosis Launches into Phase II

Hereditary hemochromatosis is a genetic form of a condition in which the body builds up too much iron. To read more about hemochromatosis, click here. La Jolla Pharmaceutical Company has…

Continue Reading Study of LJPC-401 Treatment for Hereditary Hemochromatosis Launches into Phase II